Skip to content
Loading...

Season 6, Episode 15 - What‘s hot in viral hepatitis in 2024?

This session will cover a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk will provide you with valuable insights through an up-to-date overview of the latest developments and challenges in the field.

Faculty: Thomas Berg (Moderator), Jordan Feld (Faculty), Norah Terrault (Faculty), Heiner Wedemeyer (Faculty)

This episode is scheduled in honour of the United States’ Viral Hepatitis Awareness Month.

This EASL Studio is supported by GSK and Vir Biotechnology.
EASL has received no input from GSK or Vir Biotechnology with regards to the content of this programme.

Related episodes:

Back To Top